NF2 Therapeutics, Inc.
PrivateLast Round
Angel
Jan 1, 2022
Company Overview
NF2 Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was an Angel round in January 2022.
NF2 Therapeutics, Inc. is a biotechnology company that develops therapies for neurofibromatosis type 2 and related disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NF2 Therapeutics, Inc. Comparables
Compare NF2 Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mulberry Biotherapeutics | 86% | |
| Santo Therapeutics | 84% | |
| Merck | 66% |
For institutional investors. Book with your work email.
NF2 Therapeutics, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
NF2 Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Beacon Angels | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2022
Beacon Angels participated in the round.
For institutional investors. Book with your work email.
NF2 Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NF2 Therapeutics, Inc.'s valuation, stock price, and market status.
Is NF2 Therapeutics, Inc. a public or private company?
NF2 Therapeutics, Inc. is a private company.
What is the current stock price of NF2 Therapeutics, Inc.?
NF2 Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks NF2 Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NF2 Therapeutics, Inc. worth (valuation)?
Valuation information for NF2 Therapeutics, Inc. is not publicly available.
Can I buy NF2 Therapeutics, Inc. stock?
NF2 Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NF2 Therapeutics, Inc.'s last funding round?
NF2 Therapeutics, Inc.'s most recent funding round was Angel on January 1, 2022.
Who are the main investors in NF2 Therapeutics, Inc.?
Key investors in NF2 Therapeutics, Inc. include Beacon Angels.
Will NF2 Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for NF2 Therapeutics, Inc..
How can I track NF2 Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in NF2 Therapeutics, Inc.'s shares on secondary markets.